FOLD - Amicus Therapeutics, Inc.

Top Stock Signal for 05-13-2022
Loading Chart FOLD

Stock Signal Information


Top Stock Signal: FOLD
Report Date: 05-13-2022
Company: Amicus Therapeutics, Inc. (FOLD)
Sector: Healthcare
Industry: Biotechnology

FOLD Technical Analysis

Company Contact

Amicus Therapeutics, Inc. (FOLD)
1 Cedarbrook Dr
Cranbury, NEW JERSEY 08512
Phone: 16096622000
Website: http://amicusrx.com
CEO: Mr. John Crowley

FOLD, Amicus Therapeutics, Inc.

FOLD Amicus Therapeutics, Inc. Logo Image

NASDAQ, Nasdaq Global Market

Company Profile

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Top Stock Signals

daily stock signals, free stock option signals, daily stock signals

About Top Stock Signals

Good stock signals have been found on this server. That is all we know.

Phone: +1 (407) 559-7228
Email: [email protected]

About Us | Newsletter | Members

Most Active
Top Gainers
Top Losers